Breast Cancer Clinical Trial
Official title:
Psychosocial Impact of Cancer-Related Female Infertility
The success of cancer treatment combined with the trend to delay childbearing is increasing
the numbers of women survivors whose childbearing has been interrupted by cancer. For some,
treatment has resulted in infertility. Others have been advised to delay pregnancy until a
certain follow-up interval or have new fears that pregnancy could be a risk to maternal
health. Not least is the concern that children born after a mother's cancer would face
increased risks for birth defects or cancer.
The specific aims of this project are as follows:
1. To measure the impact of cancer-related interruption of childbearing on women's
long-term emotional well-being and health-related quality of life, over and above other
demographic and cancer-related factors
2. To find out if becoming a biological or social mother after cancer treatment decreases
the long-term psychosocial impact of interrupted childbearing compared to remaining
childless
3. To refine the psychometric properties of questionnaires for female cancer survivors
measuring Distress about Cancer-Related Childbearing Issues and Attitudes towards
Parenthood after Cancer
4. To define targets for a future intervention to improve female survivors' knowledge
about childbearing after cancer, decrease distress associated with interrupted
childbearing, and promote peer support.
Women from the M. D. Anderson tumor registry who were diagnosed from 1992 to 1997 with
invasive cervical cancer, breast cancer, Hodgkin's disease, or non-Hodgkin's lymphoma will
be asked to participate. Researchers have chosen these types of cancers because they are the
most common cancers in women of reproductive age. In addition, many of the standard
treatments for these diseases have the potential to cause infertility.
If you agree to participate, you will be asked to complete a survey over the phone. Topics
that will be addressed by the survey include demographic information (such as age, sex,
etc.), medical information, health-related quality of life, emotional distress, and stress
related to interrupted childbearing. Some other topics include anxiety related to the impact
of cancer on childbearing, menopausal symptoms, spiritual well-being, relationship
happiness, sexual satisfaction, and attitudes about parenthood after cancer. The phone
survey should take around 90 minutes to complete.
If you feel distressed at any time during or after your participation in this study, you
will be given a referral for professional counseling.
THIS IS AN INVESTIGATIONAL STUDY.
Up to 2091 women will be invited to participate in this study. All will be enrolled at M. D.
Anderson.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |